| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |